6291-88-9 Usage
Description
3,3'-sulphonyldipropionic acid, with the molecular formula C9H14O6S, is a dicarboxylic acid featuring a sulfonic acid group. It is a white crystalline solid that is soluble in water and polar organic solvents. This chemical compound is widely recognized for its role as an intermediate in the synthesis of various organic compounds.
Uses
Used in Polymer Production:
3,3'-sulphonyldipropionic acid is utilized as a monomer in the production of polymers, specifically polyesters and polyamides. Its unique properties contribute to the development of polymers with specific characteristics for various applications.
Used in Pharmaceutical Synthesis:
As a chemical intermediate, 3,3'-sulphonyldipropionic acid plays a crucial role in the synthesis of pharmaceuticals. Its chemical structure allows for the creation of a range of medicinal compounds, enhancing the development of new drugs.
Used in Agrochemical Production:
3,3'-sulphonyldipropionic acid is also employed as an intermediate in the synthesis of agrochemicals, contributing to the development of products that support agricultural practices and crop protection.
Used in Detergent and Surfactant Manufacturing:
Leveraging its surfactant properties, 3,3'-sulphonyldipropionic acid serves as a raw material in the production of detergents and surfactants. Its inclusion improves the effectiveness of these cleaning agents.
Used in Specialty Chemicals Synthesis:
3,3'-sulphonyldipropionic acid is used as an intermediate in the synthesis of other specialty chemicals, broadening its applications across various industries.
Used in Material Development:
3,3'-sulphonyldipropionic acid has potential applications in the development of new materials, such as ion-exchange resins and functional materials for diverse industrial purposes, showcasing its versatility in material science.
Check Digit Verification of cas no
The CAS Registry Mumber 6291-88-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,2,9 and 1 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 6291-88:
(6*6)+(5*2)+(4*9)+(3*1)+(2*8)+(1*8)=109
109 % 10 = 9
So 6291-88-9 is a valid CAS Registry Number.
6291-88-9Relevant articles and documents
Jolles-Bergeret
, p. 349,350-351 (1974)
The cysteine dioxygenase homologue from Pseudomonas aeruginosa is a 3-mercaptopropionate dioxygenase
Tchesnokov, Egor P.,Fellner, Matthias,Siakkou, Eleni,Kleffmann, Torsten,Martin, Lois W.,Aloi, Sekotilani,Lamont, Iain L.,Wilbanks, Sigurd M.,Jameson, Guy N.L.
, p. 24424 - 24437 (2015/10/19)
Thiol dioxygenation is the initial oxidation step that commits a thiol to important catabolic or biosynthetic pathways. The reaction is catalyzed by a family of specific non-heme mononuclear iron proteins each of which is reported to react efficiently with only one substrate. This family of enzymes includes cysteine dioxygenase, cysteamine dioxygenase, mercaptosuccinate dioxygenase, and 3-mercaptopropionate dioxygenase. Using sequence alignment to infer cysteine dioxygenase activity, a cysteine dioxygenase homologue from Pseudomonas aeruginosa (p3MDO) has been identified. Mass spectrometry of P. aeruginosa under standard growth conditions showed that p3MDO is expressed in low levels, suggesting that this metabolic pathway is available to the organism. Purified recombinant p3MDO is able to oxidize both cysteine and 3-mercaptopropionic acid in vitro, with a marked preference for 3-mercaptopropionic acid. We therefore describe this enzyme as a 3-mercaptopropionate dioxygenase. M?ssbauer spectroscopy suggests that substrate binding to the ferrous iron isthrough the thiol but indicates that each substrate could adopt different coordination geometries. Crystallographic comparison with mammalian cysteine dioxygenase shows that the overall active site geometry is conserved but suggests that the different substrate specificity can be related to replacement of an arginine by a glutamine in the active site.
COMPOUNDS AND THEIR METHODS OF USE
-
Paragraph 0243; 0244, (2014/05/25)
Compounds and compositions comprising compounds that inhibit glutaminase are described herein. Also described herein are methods of using the compounds that inhibit glutaminase in the treatment of cancer.
